Ravi Kiran Kaja, PhD, explains how USP’s industry-wide initiative aims to build confidence in trace-level extractables and leachables results.
News|Articles|March 2, 2003
- Pharmaceutical Technology-03-02-2003
- Volume 27
- Issue 3
Concept Paper Discusses Update of Aspetic Processing Guidelines
Author(s)Hallie Forcinio
The recently issued FDA concept paper about aseptic processing shows how the current guidelines could be expanded and makes recommendations for alternatives to traditional cleanroom installations such as isolator-equipped aseptic filling lines and blow?fill?seal equipment.
Advertisement
Articles in this issue
over 23 years ago
The Clarification of Bioreactor Cell Cultures for Biopharmaceuticalsover 23 years ago
Standards for Supplementsover 23 years ago
Outsourcing Outlook March 2003over 23 years ago
March 2003Advertisement
Related to this article
Science, circularity, regulation, and technology are reshaping how the industry develops packaging for medicines.
AI accountability, faster FDA pathways, rare disease CMC review, and next-gen GLP-1 formulation lead this week’s PharmTech roundup.
MASH and cardiomyopathy AI collaboration: AstraZeneca pays insitro $40M upfront for target discovery, then leads clinical development and CMC planning.
Nate Edwards of Arya Consulting moderates a discussion with Elisabeth Gardiner of Tevard Biosciences and Donny Xu of the RTW Institute about rare disease treatment development and navigating the FDA’s Rare Pediatric Disease Priority Review Voucher Program.
NVIDIA’s $250M, five-year compute donation funds UK agentic AI safety research, with implications for how GMP teams validate and govern autonomous AI.
Richard Jaenisch explains what FDA's real-world use case database means for CMC and quality teams navigating NAMs.
This article examines how modern automation platforms create the digital foundation required for Pharma 4.0 by integrating manufacturing systems, centralized data management, Industrial Internet of Things connectivity, electronic batch production records, and AI-driven analytics.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
OpenAI Bets on Accelerating Drug Development Timelines With Orchestra Bio
2
Germany’s Medical Biotechnology Sector is Flourishing
3
PharmTech AI Pulse Check: Why Pharma Should Weigh In on FDA's Generative AI Paper
4
AAPS PharmSci 360 2026: System Suitability Standards in E&L Testing
5